• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

10例存活6年以上的多发性骨髓瘤病例报告

[Report of 10 cases of multiple myeloma surviving more than 6 years].

作者信息

Shan Y D, Zhang Z N, Ge C W

机构信息

Peking Union Medical College Hospital, Beijing.

出版信息

Zhonghua Nei Ke Za Zhi. 1991 Dec;30(12):766-8, 790-1.

PMID:1815884
Abstract

Ten cases of multiple myeloma seen in PUMC hospital survived more than six years. 4 of them survived more than ten years. 6 patients were of IgA type. Features of those cases included: (1) symptoms mild; (2) incidence of anemia low; (3) percentage of tumor cell in bone marrow also relatively low; (4) blood urea nitrogen, creatinine and calcium normal; (5) maintenance therapy rather long. The prognostic factors and the current general situation of treatment were briefly discussed.

摘要

北京协和医院收治的10例多发性骨髓瘤患者存活超过6年。其中4例存活超过10年。6例患者为IgA型。这些病例的特点包括:(1)症状较轻;(2)贫血发生率低;(3)骨髓中肿瘤细胞百分比也相对较低;(4)血尿素氮、肌酐和钙正常;(5)维持治疗时间较长。文中简要讨论了预后因素及当前的总体治疗情况。

相似文献

1
[Report of 10 cases of multiple myeloma surviving more than 6 years].10例存活6年以上的多发性骨髓瘤病例报告
Zhonghua Nei Ke Za Zhi. 1991 Dec;30(12):766-8, 790-1.
2
[Clinical response to the treatment of multiple myeloma].[多发性骨髓瘤治疗的临床反应]
Rinsho Ketsueki. 1989 Aug;30(8):1216-9.
3
Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies.促红细胞生成素具有抗骨髓瘤作用——这一假说基于一项临床观察,并得到了动物研究的支持。
Eur J Haematol. 2004 Mar;72(3):155-65. doi: 10.1046/j.0902-4441.2003.00190.x.
4
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.多发性骨髓瘤首次缓解诱导治疗后的自体干细胞移植。法国多发性骨髓瘤自体移植登记处报告。
Stem Cells. 1995 Aug;13 Suppl 2:132-9. doi: 10.1002/stem.5530130721.
5
[Clinical and laboratory analysis of the cases of multiple myeloma with over 5-year survival time from the beginning of the antineoplastic treatment].[抗肿瘤治疗开始后生存时间超过5年的多发性骨髓瘤病例的临床与实验室分析]
Acta Haematol Pol. 1991;22(1):42-7.
6
An abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era.在硼替佐米时代,异常非高倍体核型是多发性骨髓瘤的一个重要不良预后因素。
Am J Hematol. 2010 Oct;85(10):752-6. doi: 10.1002/ajh.21812.
7
[Long-term survival and prognostic factors in multiple myeloma treated with conventional chemotherapy. Report of 109 cases].
Tunis Med. 2000 Dec;78(12):705-12.
8
Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications.多发性骨髓瘤的分类与预后评估。一项关于生存及化疗反应与免疫类型、20个单一预后因素、15种临床分期系统及6种形态学分类之间关系的回顾性研究。
Panminerva Med. 1991 Apr-Jun;33(2):93-110.
9
Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.III期多发性骨髓瘤:脊柱骨髓磁共振成像的临床及预后价值
Radiology. 1998 Dec;209(3):653-60. doi: 10.1148/radiology.209.3.9844655.
10
[Multiple myeloma with 5-year survival. Study of initial prognostic factors. Role of beta-2-microglobulin].[多发性骨髓瘤的5年生存率。初始预后因素研究。β2-微球蛋白的作用]
Rev Rhum Mal Osteoartic. 1985 Nov;52(11):619-23.